COMMUNIQUÉS West-GlobeNewswire

Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025
09/05/2025
SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked [...]
Rectify Pharma Presents Translational Data for Novel Positive Functional Modulator Demonstrating Improved Biliary and Liver Health at EASL 2025
09/05/2025
Oral dual-targeted ABCB4/BSEP positive functional modulator (PFM) improved cholestatic and cholangitis markers in orthogonal models of hepatobiliary disease Data reinforce the potential of this differentiated mechanism [...]
Sanuwave Announces Q1 FY2025 Financial Results
09/05/2025
Q1 2025 revenues were $9.3 million , up 61% from $5.8 million in Q1 2024. This represents the highest Q1 quarterly revenues in Company history. Q1 2025 gross margin was 79.0% , versus 72.6% in Q1 2024. GAAP Operating [...]
Artax Biopharma presents Phase 2a results for oral Nck modulator AX-158 in late-breaking session at the Society for Investigative Dermatology 2025 Annual Meeting
09/05/2025
First small molecule to modulate the fundamental mechanism of T cell activation underlying autoimmune pathology Statistically significant improvements in T cell and psoriasis-related biomarkers in line with PASI [...]
RadNet, Inc. to Present at the Bank of America Securities 2025 Healthcare Conference on May 13th, 2025
09/05/2025
LOS ANGELES, May 09, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
Florida Governor Ron DeSantis Joins Olympia Pharmaceuticals in Ribbon-Cutting Ceremony for New Sister Pharmacy, Wesley Pharmaceuticals
09/05/2025
The new Orlando-based 503B pharmacy plans to hire 100 Floridians this year while reducing medication costs and increasing transparency for consumers ORLANDO, Fla., May 09, 2025 (GLOBE NEWSWIRE) -- Wesley Pharmaceuticals [...]
Gyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
09/05/2025
Net Income of $3.7 million; reaffirms Full-Year Revenue Guidance of $118–$128 million Q1 2025 revenue of $22.1 million; GAAP basic EPS: $0.03 Completed data collection and achieved database lock for the pivotal Phase 3 [...]
Sumatra Slim Belly Tonic Reviews: What Users Are Saying About This Blue Tonic for Weight Loss
09/05/2025
HOUSTON, May 09, 2025 (GLOBE NEWSWIRE) -- Losing weight today can feel like a bigger challenge than ever before. Despite trying endless diets, workout plans, and the latest supplements, many of us still struggle with [...]
ProstaVive Reviews 2025 (New Medical Report): Shocking User Results, Key Ingredients & Complaints
09/05/2025
DALLAS, May 09, 2025 (GLOBE NEWSWIRE) -- As prostate health becomes a growing concern for millions of aging men, ProstaVive has quickly risen to prominence, dominating conversations across wellness forums, trending on [...]
ProDentim Reviews and Complaints (May 2025): Users Share Results and Address Common Concerns
09/05/2025
BIRMINGHAM, Ala., May 09, 2025 (GLOBE NEWSWIRE) -- ProDentim has quickly become a popular probiotic supplement in the oral health world, but with so many health trends, it's natural to wonder if it’s effective. Over 30, [...]
Bavarian Nordic Announces Interim Results for the First Three Months of 2025
09/05/2025
COPENHAGEN, Denmark , May 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2025. Revenue for the first three months increased by [...]
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 11, 2025
09/05/2025
REGULATED INFORMATION May 9, 2025, 7:00am CET / 1:00am ET NYXOAH SA (Euronext Brussels: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium (hereinafter the “ Company ”) Invitation to attend the annual and the [...]
Invitation à assister à l'assemblée générale annuelle et extraordinaire des actionnaires de la Société qui se tiendra le 11 juin 2025
09/05/2025
INFORMATIONS RÉGLEMENTÉES le 9 mai 2025, 7:00h CET / 1:00h ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgique (ci-après la « Société ») Invitation à assister à l' [...]
Zealand Pharma announces closing of collaboration and license agreement with Roche
09/05/2025
Company announcement – No. 12 / 2025 Zealand Pharma announces closing of collaboration and license agreement with Roche Copenhagen, Denmark, May 9, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights
09/05/2025
SAN DIEGO, May 08, 2025 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq-CM: TSBX) , a biotechnology company historically focused on the development of a differentiated approach to [...]
Keros Reinforces Commitment to Maximizing Stockholder Value
08/05/2025
Responds to Recent Public Stockholder Communications Urges Stockholders to Protect Their Investment by Voting “FOR” the Company’s Highly Qualified Director Nominees LEXINGTON, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- [...]
Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update
08/05/2025
-- Company delivers on mission to transform women’s health with innovative solutions, including FemaSeed ® for first-line infertility treatment and FemBloc ® non-surgical permanent birth control (full system approval [...]
Nova Leap Health Corp. Posts Q1 2025 Results
08/05/2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 08, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
VitalHub Reports First Quarter 2025 Results
08/05/2025
Annual Recurring Revenue (ARR) ⁽¹⁾ up 54% YoY to $73.7 million Total Revenue up 42% YoY to $21.7 million Adjusted EBITDA ⁽¹⁾ up 39% YoY to $5.6 million TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (the “ [...]

Pages